In vivo monitoring of tissue pharmacokinetics of liposome/drug using MRI: Illustration of targeted delivery

Magnetic Resonance in Medicine

Volumn 51, Issue 6, 2004, Pages 1153-1162

  Viglianti, Benjamin L ^a   Abraham, Sheela A ^b,c   Michelich, Charles R ^a   Yarmolenko, Pavel S ^d   MacFall, James R ^d   Bally, Marcel B ^b,c   Dewhirst, Mark W ^a,d  

^a Duke University   (United States)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Chemotherapy; Hyperthermia; Liposomes; Pharmacokinetics

Indexed keywords

CHEMOTHERAPY; CONTROLLED DRUG DELIVERY; HYPERTHERMIA THERAPY; LIPOSOMES; MANGANESE COMPOUNDS; MICROCHANNELS; PHARMACOKINETICS; TUMORS;

CONCENTRATION DISTRIBUTIONS; DRUG CONCENTRATION; DRUG DELIVERY AND RELEASE; HYPERTHERMIA; LIPOSOMAL FORMULATION; TARGETED DELIVERY; TEMPERATURE SENSITIVE LIPOSOMES; THERMALLY SENSITIVES;

TARGETED DRUG DELIVERY;

CONTRAST MEDIUM; DOXORUBICIN; DRUG; LIPOSOME; MAGNESIUM SULFATE;

ANIMAL MODEL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MONITORING; DRUG RELEASE; DRUG TARGETING; DRUG TISSUE LEVEL; HYPERTHERMIA; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHARMACOKINETICS; TEMPERATURE SENSITIVITY; TUMOR MODEL;

EID: 2942753811     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.20074     Document Type: Article

References (31)

1. Kong G, Dewhirst MW. Hyperthermia and liposomes. Int J Hyperthermia 1999;15:345-370.
2. Bhatnagar A, Hustinx R, Alavi A. Nuclear imaging methods for non-invasive drug monitoring. Adv Drug Deliv Rev 2000;41:41-54.
3. Holland JF, Frei E (eds.). Cancer Medicine 6th ed, vol. 1-2. Hamilton, Ontario: BC Decker; 2003.
4. Abraham S, Edwards K, Karlsson G, MacIntosh S, Mayer L, McKenzie C, Bally M. Formation of transition metal-doxorubicin complexes inside liposomes. Biochim Biophys Acta 2002;1565:41.
5. Wehrli FW, Shaw D, Kneeland JB. Biomedical magnetic resonance imaging: principles, methodology, and applications. New York: Virchow; 1988.
6. Morgan L, Nolle A. Proton spin relation in aqueous solutions of paramagnetic ions II: Cr+++, Mn++. Ni++, Cu++, and Gd++. J Chem Phys 1959;31:365.
7. Liang Z-P, Lauterbur PC. Principles of magnetic resonance imaging: a signal processing perspective. New York: SPIE Optical Engineering Press; IEEE Press; 2000.
8. Matteucci ML, Anyarambhatla G, Rosner G, Azuma C, Fisher PE, Dewhirst MW, Needham D, Thrall DE. Hyperthermia increases accumulation of technetium-99m-labeled liposomes in feline sarcomas. Clin Cancer Res 2000;6:3748-3755.
9. Leander P, Mansson S, Ege T, Besjakov J. CT and MR imaging of the liver using liver-specific contrast media. A comparative study in a tumour model. Acta Radiol 1996;37:242-249.
10. Niesman MR, Bacic GG, Wright SM, Swartz HJ, Magin RL. Liposome encapsulated MnCl2 as a liver specific contrast agent for magnetic resonance imaging. Invest Radiol 1990;25:545-551.
11. Schwendener RA, Wuthrich R, Duewell S, Wehrli E, von Schulthess GK. A pharmacokinetic and MRI study of unilamellar gadolinium-, manganese-, and iron-DTPA-stearate liposomes as organ-specific contrast agents. Invest Radiol 1990;25:922-932.
12. Suga K, M MP, Ogasawara N, Okazaki H, Matsunaga N. Potential of Gd-DTPA-mannan liposome particles as a pulmonary perfusion MRI contrast agent: an initial animal study. Invest Radiol 2001;36:136-145.
13. Unger E, Fritz T, Shen DK, Wu G. Manganese-based liposomes. Comparative approaches. Invest Radiol 1993;28:933-938.
14. Chu WJ, Simor T, Elgavish GA. In vivo characterization of Gd(BME-DTTA), a myocardial MRI contrast agent: tissue distribution of its MRI intensity enhancement, and its effect on heart function. NMR Biomed 1997;10:87-92.
15. Unger E, Shen DK, Wu GL, Fritz T. Liposomes as MR contrast agents: pros and cons. Magn Reson Med 1991;22:304-308; discussion 313.
16. Bacic G, Niesman MR, Bennett HF, Magin RL, Swartz HM. Modulation of water proton relaxation rates by liposomes containing paramagnetic materials. Magn Reson Med 1988;6:445-458.
17. Kong G, Braun RD, Dewhirst MW. Characterization of the effect of hyperthermia on nanoparticle extravasation from tumor vasculature. Cancer Res 2001;61:3027-3032.
18. Kong G, Anyarambhatla G, Petros WP, Braun RD, Colvin OM, Needham D, Dewhirst MW. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release. Cancer Res 2000;60:6950-6957.
19. Kong G, Braun RD, Dewhirst MW. Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size. Cancer Res 2000;60:4440-4445.
20. Needham D, Anyarambhatla G, Kong G, Dewhirst MW. A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model. Cancer Res 2000;60:1197-1201.
21. Cheung BC, Sun TH, Leenhouts JM, Cullis PR. Loading of doxorubicin into liposomes by forming Mn2+-drug complexes. Biochim Biophys Acta 1998;1414:205-216.
22. Mayer LD, Hope MJ, Cullis PR, Janoff AS. Solute distributions and trapping efficiencies observed in freeze-thawed multilamellar vesicles. Biochim Biophys Acta 1985;817:193-196.
23. Fiske CH, Subbarow Y. The colour/metric determination of phosphorus. J Biol Chem 2 1925:375-395.
24. Qiu H, Cofer G, Hedlund L, Johnson GA. Automated feedback control of body temperature for small animal studies with MR microscopy. IEEE Trans Biomed Eng 1997;44:1107-1113.
25. Grant JP, Wells SA Jr. Tumor resistance in rats immunized to fetal tissues. J Surg Res 1974;16:533-540.
26. Takehara Y, Sakahara H, Masunaga H, Isogai S, Kodaira N, Takeda H, Saga T, Nakajima S, Sakata I. Tumour enhancement with newly developed Mn-metalloporphyrin (HOP-9P) in magnetic resonance imaging of mice. Br J Cancer 2001;84:1681-1685.
27. Fossheim SL, Fahlvik AK, Klaveness J, Muller RN. Paramagnetic liposomes as MRI contrast agents: influence of liposomal physicochemical properties on the in vitro relaxivity. Magn Reson Imag 1999;17:83-89.
28. Yuan F, Dellian M, Fukumura D, Leunig M, Berk DA, Torchilin VP, Jain RK. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res 1995;55:3752-3756.
29. Unger EC, Shen DK, Fritz TA. Status of liposomes as MR contrast agents. J Magn Reson Imag 1993;3:195-198.
30. Bulte JW, de Cuyper M, Despres D, Frank JA. Short- vs. long-circulating magnetoliposomes as bone marrow-seeking MR contrast agents. J Magn Reson Imag 1999;9:329-335.
31. Lokling KE, Skurtveit R, Fossheim SL, Smistad G, Henriksen I, Klaveness J. pH-sensitive paramagnetic liposomes for MRI: assessment of stability in blood. Magn Reson Imag 2003;21:531-540.